These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1534662)
1. Serotonin related functions in panic-anxiety: a critical overview. Coplan JD; Gorman JM; Klein DF Neuropsychopharmacology; 1992 May; 6(3):189-200. PubMed ID: 1534662 [TBL] [Abstract][Full Text] [Related]
2. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety. Murphy DL; Pigott TA J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026 [TBL] [Abstract][Full Text] [Related]
3. Serotonin function in panic disorder: important, but why? Maron E; Shlik J Neuropsychopharmacology; 2006 Jan; 31(1):1-11. PubMed ID: 16132063 [TBL] [Abstract][Full Text] [Related]
4. Panic disorder: the potential role of serotonin reuptake inhibitors. Sheehan DV; Zak JP; Miller JA; Fanous BS J Clin Psychiatry; 1988 Aug; 49 Suppl():30-6. PubMed ID: 3045109 [TBL] [Abstract][Full Text] [Related]
7. Cooperative regulation of anxiety and panic-related defensive behaviors in the rat periaqueductal grey matter by 5-HT1A and μ-receptors. Roncon CM; Biesdorf C; Coimbra NC; Audi EA; Zangrossi H; Graeff FG J Psychopharmacol; 2013 Dec; 27(12):1141-8. PubMed ID: 23598399 [TBL] [Abstract][Full Text] [Related]
8. Serotonin-specific drugs for anxiety and depressive disorders. Charney DS; Krystal JH; Delgado PL; Heninger GR Annu Rev Med; 1990; 41():437-46. PubMed ID: 2139556 [TBL] [Abstract][Full Text] [Related]
9. New Findings on the Neurotransmitter Modulation of Defense in the Dorsal Periaqueductal Gray. Graeff FG; Sant'Ana AB; Vilela-Costa HH; Zangrossi H CNS Neurol Disord Drug Targets; 2015; 14(8):988-95. PubMed ID: 26350338 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic treatment of panic disorder. Stein M; Steckler T; Lightfoot JD; Hay E; Goddard AW Curr Top Behav Neurosci; 2010; 2():469-85. PubMed ID: 21309122 [TBL] [Abstract][Full Text] [Related]
12. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications]. Moulignier A Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037 [TBL] [Abstract][Full Text] [Related]
13. Differential response patterns to MAO inhibitors and tricyclics. Nies A J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487 [TBL] [Abstract][Full Text] [Related]
14. Variability in the effects of 5-HT-related compounds in experimental models of anxiety: evidence for multiple mechanisms of 5-HT in anxiety or never ending story? Griebel G Pol J Pharmacol; 1996; 48(2):129-36. PubMed ID: 9112642 [TBL] [Abstract][Full Text] [Related]
15. New findings in the treatment of panic disorder. Westenberg HG; Den Boer JA Pharmacopsychiatry; 1993 May; 26 Suppl 1():30-3. PubMed ID: 8378420 [TBL] [Abstract][Full Text] [Related]
16. The dual role of serotonin in defense and the mode of action of antidepressants on generalized anxiety and panic disorders. Graeff FG; Zangrossi H Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):207-17. PubMed ID: 20528764 [TBL] [Abstract][Full Text] [Related]
17. Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders. Humble M; Wistedt B Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():21-39. PubMed ID: 1431019 [TBL] [Abstract][Full Text] [Related]